Worldwide Antibody-Drug Conjugates Market is Expected to Grow at a CAGR of 25.8?tween 2021 and 2028 by Emergen Research
Research Reports
Feb 21, 2022
Antibody-drug conjugates are highly targeted therapies that use biopharmaceutical drugs comprising monoclonal antibodies to target tumor cell specific antigens and extremely potent anti-cancer drugs linked through chemical linker. ADCs are considered a powerful and highly effective class of therapeutic agents used in oncology and hematology. ADC technology is also used outside of cancer-related indications.
The Global Antibody-Drug Conjugates Market Report offers extensive knowledge and information about the Antibody-Drug Conjugates market pertaining to market size, market share, growth influencing factors, opportunities, and current and emerging trends. The report is formulated with the updated and latest information of the global Antibody-Drug Conjugates market further validated and verified by the industry experts and professionals.
Antibody-Drug Conjugates (ADCs) market size is expected to reach USD 20.01 Billion at a steady revenue CAGR of 25.8% in 2028, according to latest analysis by Emergen Research. Increasing prevalence of cancer along with growing geriatric population is driving antibody-drug conjugates market revenue growth. Antibody drug conjugates are used to treat cancer and are safer than other types of cancer therapies.
ADCs are a targeted approach to deliver medicine and chemotherapy agents to cancer cells. Almost 8.2 million persons die each year due to cancer globally. Increasing prevalence of cancer in countries across the globe has created a rapid incline in demand for ADCs. Market players are collaborating to share resources and product knowledge to enhance effectiveness and efficiency of solutions and offerings and to develop even more advanced and effective drugs and therapies.
High cost and stringent regulations are some key factors hampering market growth. Disadvantages of ADCs include challenges of linker technology because synthesis/design of bio-functional is quite challenging due to requirements of specialized teams. ADC must be manufactured in an aseptic environment and operating personnel should be protected from very toxic drug compounds, thus presenting operational difficulties.
Get Free Sample PDF Copy Of This Report At https://www.emergenresearch.com/request-sample/754
The report, additionally, offers a comprehensive SWOT analysis and Porter’s Five Forces analysis to offer a better understanding of the competitive landscape of the industry. It also covers strategies adopted by prominent players such as mergers and acquisitions, collaborations, joint ventures, product launches, and brand promotions, among others. The report aims to offer the readers a holistic understanding of the relevant features of the industry.
Some major companies operating in the global market include:- Oxford BioTherapeutics, Bayer AG, Immunomedics Inc., Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Pfizer Inc., ImmunoGen Inc., AbbVie Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2021-2028 & Sales with a thorough analysis of the markets competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Some Key Highlights From the Report
In July 2021, ProfoundBio announced completion of USD 55 million Series A funding on advance novel antibody-drug conjugate portfolio. The financing is being led by Lilly Asia Venture and co-led by LYFE Capital, with participation from Oriza and Sequoia Capital China. ProfoundBio will use the funds to accelerate development of ADCs and IO therapeutics.
Non-cleavable linkage segment accounted for larger revenue share in 2020 owing to greater advantages over cleavable linkers due to increased plasma stability. These linkers can potentially offer a greater therapeutic window due to the fact that the payload derivative from non-cleavable ADCs can kill target cells. It also provides great tolerability and stability.
Lung cancer is among the leading causes of deaths in both men and women globally. Despite development in treatments, patients with cancer continue to suffer with limited treatment options. ADC has emerged as a significant therapy for lung cancer as it has tumor specificity and powerful tumor-killing effect.
Analysis of the segments and their growth projection is carried out by extensive historical and current analysis of the market scenario. Further, the report offers details about the factors and features of the Antibody-Drug Conjugates market expected to boost the growth of the industry in the coming years.
Emergen Research has segmented the global Antibody-Drug Conjugates market on the basis of technology, application, end-use, and region:
Technology Outlook (Revenue, USD Billion; 2018–2028)
Cleavable Linker
Non-Cleavable Linker
Application Outlook (Revenue, USD Billion; 2018–2028)
Blood Cancer
Leukemia
Lymphoma
Brain Tumor
Ovarian Cancer
Breast Cancer
Lung Cancer
Others
End-use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Research Institute
Clinics
For more informative information, please visit us https://www.emergenresearch.com/industry-report/antibody-drug-conjugates-market
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
What is the key information extracted from the report?
Extensive information on factors estimated to affect the Market growth and market share during the forecast period is presented in the report.
The report offers the present scenario and future growth prospects Market in various geographical regions.
The competitive landscape analysis on the market as well as the qualitative and quantitative information is delivered.
The SWOT analysis is conducted along with Porter’s Five Force analysis.
The in-depth analysis provides an insight into the Market, underlining the growth rate and opportunities offered in the business.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography (North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Key Questions Answered in the Report:
What is the growth rate of the Antibody-Drug Conjugates market? What is the anticipated market valuation of Antibody-Drug Conjugates industry by 2028?
What are the key growth driving and restraining factors of the Antibody-Drug Conjugates market?
Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
What are the key opportunities and growth prospects of the Antibody-Drug Conjugates industry over the forecast period?
Which region is expected to show significant growth in the coming years?
Proceed To Buy https://www.emergenresearch.com/select-license/754
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2028
Chapter 3. Key Insights
Chapter 4. Antibody-Drug Conjugates (ADCs) Market Segmentation & Impact Analysis
4.1. Antibody-Drug Conjugates (ADCs) Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increased incidence of cancer globally
4.2.2.2. Advancement in medical technology
4.2.3. Market restraints analysis
4.2.3.1. High cost of procedures
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Continued…!
Thank you for reading our report. Please connect with us to know more about the report or for requesting the customization of the report. Our team will ensure the report is best suited to your requirements.
Explore More Related Articles from Emergen Research
Electric Vehicle Testing, Inspection, and Certification Market https://www.emergenresearch.com/industry-report/electric-vehicle-testing-inspection-and-certification-market
Biomaterials Market By Type https://www.emergenresearch.com/industry-report/biomaterials-market
Emulsifiers Market By Product Type https://www.emergenresearch.com/industry-report/emulsifiers-market
Human Capital Management Market Growth https://www.emergenresearch.com/industry-report/human-capital-management-market
Top 10 Leading Companies Operating in Affective Computing Market https://www.emergenresearch.com/blog/top-10-leading-companies-operating-in-affective-computing-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Information:
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Tags:
Reportedtimes, PR-Wirein, iCN Internal Distribution, Research Newswire, English